Crescent Biopharma (CBIO) Revenue (2013 - 2026)
Crescent Biopharma (CBIO) reported Revenue of $1.0 million for Q1 2026, up 1285.33% on a QoQ basis from $75000.0 in Q2 2022.
Crescent Biopharma (CBIO) has 8 years of Revenue data on file, last reported at $1.0 million in Q1 2026.
- Quarterly Revenue changed N/A year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (changed N/A YoY) and the FY2025 annual result came in at $10.8 million, changed N/A from the prior year.
- Revenue improved to $1.0 million in Q1 2026 per CBIO's latest filing, from $75000.0 in the prior quarter.
- Across five years, Revenue topped out at $1.0 million in Q1 2026 and bottomed at $75000.0 in Q2 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 306.30 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 2.99 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.61 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.17 Bn |
| 10 | Crescent Biopharma | 569.36 Mn | 380.20 Mn | - | 1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.04 Mn |
| Jun 30, 2022 | 75,000.00 |
| Dec 31, 2021 | 17,625.00 |
| Sep 30, 2021 | 86,560.00 |
| Jun 30, 2021 | 142.00 |
| Mar 31, 2021 | 1.06 Mn |
| Dec 31, 2020 | 162,935.00 |
| Sep 30, 2020 | 1.00 Mn |
| Mar 31, 2020 | 9.00 Mn |
| Sep 30, 2016 | 18,500.00 |
| Dec 31, 2015 | 35,375.00 |
| Sep 30, 2015 | 35,375.00 |
| Jun 30, 2015 | 20.00 Mn |
| Jun 30, 2014 | 15.03 Mn |
| Dec 31, 2013 | 77,413.00 |
| Sep 30, 2013 | 52,571.00 |
| Jun 30, 2013 | 55,074.00 |
| Mar 31, 2013 | 3.81 Mn |